Cardiology Today Current Issue
The following articles appeared in the print edition of Cardiology Today.
Table of Contents
- New knowledge, technologies yield drastic changes in cardiology over 20 years
-
- 2016: An active, exciting year in cardiology Carl J. Pepine, MD, MACC
- Impact of new US administration on cardiology practice, health care unclear L. Samuel Wann, MD, MACC, FESC; Joshua D. Liberman, MD, FACC
- Website publishes risk categories for QT-prolonging drugs Raymond L. Woosley, MD, PhD
- Increased BP confers greater risk for death, HF hospitalization in black adults
- Lipid measures continue to decline among US adults
- Metabolite from gut microbes predicts mortality risk in patients with PAD
- USPSTF recommends use of statins to prevent CVD
- ART: Outcomes of single, bilateral internal-thoracic-artery-grafting similar at 5 years
-
- Healthy lifestyle can offset high genetic CAD risk
- HOPE-3: Rosuvastatin, antihypertensive drugs do not prevent cognitive decline
- Mortality link with FFR questioned in FUTURE trial
- Novel therapy targeting ANGPTL3 protein safe, effective in early study
- REDUCE LAP-HF: Transcatheter interarterial shunt device shows benefit for patients with HFpEF at 1 year
- Trial Scorecard: ATHENA-HF
- Trial Scorecard: PACE
- Trial Scorecard: REDUCE LAP-HF
-
- Trial Scorecard: SMAC-AF